Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, USP To Its Portfolio Of Off-Patent Oncology Products

Links shared publicly online about this topic.

  • 210
    total visits

Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, USP To Its Portfolio Of Off-Patent Oncology Products

medicalnewstoday.com —

Pfizer Injectables, part of Pfizer Inc.'s (NYSE: PFE) Established Products Business Unit, announced the addition of doxorubicin hydrochloride injection, USP, to Pfizer Injectables' growing portfol

View full resource at medicalnewstoday.com

Tags: Pfizer, Oncology

  • Share

Most Recently Shared on June 18, 2011 at 10:37 am By:

medical_tweets medical_tweets

Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, USP To Its Portfolio Of Off-Patent Oncology Products: Pfi.. http://dld.bz/adKtY

11 months ago...

Reply

Retweet

Favorite

Also Shared By:

MedicalFeed MedicalFeed

Advertisement